Logo image of MSS

MAISON SOLUTIONS INC-A (MSS) Stock Fundamental Analysis

NASDAQ:MSS - Nasdaq - US5606671072 - Common Stock - Currency: USD

1.28  0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to MSS. MSS was compared to 40 industry peers in the Consumer Staples Distribution & Retail industry. MSS has a bad profitability rating. Also its financial health evaluation is rather negative. MSS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

MSS had negative earnings in the past year.
In the past year MSS had a positive cash flow from operations.
MSS Yearly Net Income VS EBIT VS OCF VS FCFMSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

The Return On Assets of MSS (-3.48%) is worse than 71.79% of its industry peers.
Looking at the Return On Equity, with a value of -26.34%, MSS is doing worse than 76.92% of the companies in the same industry.
Industry RankSector Rank
ROA -3.48%
ROE -26.34%
ROIC N/A
ROA(3y)-0.86%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MSS Yearly ROA, ROE, ROICMSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 200 -200 -400

1.3 Margins

MSS has a Gross Margin of 23.92%. This is comparable to the rest of the industry: MSS outperforms 48.72% of its industry peers.
MSS's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for MSS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.25%
GM growth 5YN/A
MSS Yearly Profit, Operating, Gross MarginsMSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 -5 10 15 20

More info and screens

0

2. Health

2.1 Basic Checks

MSS does not have a ROIC to compare to the WACC, probably because it is not profitable.
MSS has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, MSS has a worse debt to assets ratio.
MSS Yearly Shares OutstandingMSS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
MSS Yearly Total Debt VS Total AssetsMSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of 1.03, we must say that MSS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.03, MSS is not doing good in the industry: 82.05% of the companies in the same industry are doing better.
MSS has a Debt/Equity ratio of 1.24. This is a high value indicating a heavy dependency on external financing.
MSS's Debt to Equity ratio of 1.24 is on the low side compared to the rest of the industry. MSS is outperformed by 71.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF N/A
Altman-Z 1.03
ROIC/WACCN/A
WACC6.65%
MSS Yearly LT Debt VS Equity VS FCFMSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 0.48 indicates that MSS may have some problems paying its short term obligations.
MSS has a Current ratio of 0.48. This is amonst the worse of the industry: MSS underperforms 92.31% of its industry peers.
MSS has a Quick Ratio of 0.48. This is a bad value and indicates that MSS is not financially healthy enough and could expect problems in meeting its short term obligations.
MSS has a Quick ratio of 0.18. This is amonst the worse of the industry: MSS underperforms 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.18
MSS Yearly Current Assets VS Current LiabilitesMSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

2

3. Growth

3.1 Past

MSS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -321.04%.
MSS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.99%.
The Revenue has been growing by 12.10% on average over the past years. This is quite good.
EPS 1Y (TTM)-321.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-369.17%
Revenue 1Y (TTM)9.99%
Revenue growth 3Y12.1%
Revenue growth 5YN/A
Sales Q2Q%125.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MSS Yearly Revenue VS EstimatesMSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M 40M 50M
MSS Yearly EPS VS EstimatesMSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MSS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MSS Price Earnings VS Forward Price EarningsMSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MSS is valued a bit more expensive than the industry average as 74.36% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 64.1
MSS Per share dataMSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MSS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAISON SOLUTIONS INC-A

NASDAQ:MSS (2/21/2025, 8:00:01 PM)

1.28

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.44%
Inst Owner Change-15.51%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap25.20M
AnalystsN/A
Price TargetN/A
Short Float %3.46%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.28
P/FCF N/A
P/OCF 34.61
P/B 2.3
P/tB N/A
EV/EBITDA 64.1
EPS(TTM)-0.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)0.04
OCFY2.89%
SpS4.63
BVpS0.56
TBVpS-0.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.48%
ROE -26.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.92%
FCFM N/A
ROA(3y)-0.86%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.25%
GM growth 5YN/A
F-Score4
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF N/A
Debt/EBITDA 31.87
Cap/Depr 225.79%
Cap/Sales 2.13%
Interest Coverage N/A
Cash Conversion 170.52%
Profit Quality N/A
Current Ratio 0.48
Quick Ratio 0.18
Altman-Z 1.03
F-Score4
WACC6.65%
ROIC/WACCN/A
Cap/Depr(3y)249.77%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-321.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-369.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.99%
Revenue growth 3Y12.1%
Revenue growth 5YN/A
Sales Q2Q%125.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-481.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1672.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-823.51%
OCF growth 3YN/A
OCF growth 5YN/A